Effective treatment of relapsed acute myeloid leukaemia with drugs chosen by DiSC assay.
Parker
A N
AN
Hutchinson
R M
RM
Chapman
C S
CS
Bosanquet
A G
AG
D000208:Acute Disease; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D003601:Cytotoxicity Tests, Immunologic; D004342:Drug Hypersensitivity / Q000517:prevention & control; D005047:Etoposide / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007951:Leukemia, Myeloid / Q000188:drug therapy*; D008875:Middle Aged; D008942:Mitoxantrone / Q000009:adverse effects / Q000627:therapeutic use; D012008:Recurrence; D014740:Vidarabine / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use
D000970:Antineoplastic Agents; D005047:Etoposide; D008942:Mitoxantrone; D014740:Vidarabine; C024352:fludarabine